Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...
Clinical portfolio strengthened through the in-licensing of phase 3-ready antibiotic ceftibuten-ledaborbactamFosmanogepix second phase 3 study initiated; two phase 3 studies in invasive fungal infecti ...
CNBC's Becky Quick spent the last six years privately handling her daughter's health journey. Now, she's ready to come forward and share her daughter's diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback